Complete ELEV Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
ELEV Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-45.51
-14971.5%
Peer Median: 56.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.00
-100.0%
Peer Median: 2.8x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ELEV's business model and current situation.
Multiple Comparison
Multiple | ELEV Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -0.4x | 56.1x | 56.1x | -100.7% | Undervalued |
EV/EBITDA | -Infinityx | 0.0x | 0.0x | -Infinity% | Undervalued |
P/S Ratio | Infinityx | 2.8x | 5.2x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$0.02B | 0.0x | 0.0x | 8.3x | |
$0.02B | 56.1x | 0.0x | 0.7x | |
$0.02B | 0.0x | 0.0x | 0.0x | |
$0.02B | 0.0x | 0.0x | 2.5x | |
$0.02B | 0.0x | 0.0x | 0.0x | |
$0.02B | 0.0x | 0.0x | 11.9x | |
$0.02B | 0.0x | 0.0x | 46.8x | |
$0.02B | 0.0x | 0.0x | 2.8x |